EFFICACY OF ETANERCEPT IN CHILD WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS

• Main Authors: T.M. Bzarova (Author), Ye.I. Alexeeva (Author), S.I. Valieva (Author), N.A. Tsurikova (Author), E.G. Chistyakova (Author), K.B. Isaeva (Author), R.V. Denisova (Author), T.V. Sleptsova (Author), E.V. Mitenko (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2011-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

The article presents a case report of severe and prolonged polyarticular rheumatoid arthritis resistant to the treatment with classic immunosuppressive agents, nonsteroidal anti-inflammatory drugs and corticosteroids. Authors describe successful treatment with soluble receptors to TNF _ - etanercept 0.4 mg for 1 kg of body weight during 36 weeks. Pain and exudative inflammation in joints lessened and the range of motions in joints increased in 4 weeks after the beginning of treatment. 9 months of treatment significantly increased the quality of life of a child and parents.Key words: children, juvenile rheumatoid arthritis, etanercept.(Voprosy sovremennoi pediatrii - Current Pediatrics. 2011; 10 (2): 184-192)

Item Description

1682-5527
1682-5535